Minneapolis-based, Boston Scientific (NYSE:BSX) backed medtech accelerator Gener8tor announced six new entrants into its summer gBeta Medtech program last Wednesday, according to a MinneInno report.
The gBeta accelerator, which is also supported by the Medical Alley Association, the University of Minnesota and the Mayo Clinic, will host the six companies in a free, seven-week long session.
The program is designed to aid the startups in gaining insight on product development and customer traction and establishing metrics to seek selection into full-time accelerators or for finding seed investors, according to the report.
Included in the accelerator are St. Louis-based Intershunt, San Francisco-based Lucia Health Guidelines, Minneapolis-based Morari Medical and SuraMedical, Houston-based Noleus Tech and Boston-based Sunrise Healthy according to MinneInno.
Intershunt is designing and developing a catheter-based minimally-invasive procedure for individuals with heart failure and Lucia Health Guidelines is looking to use artificial intelligence and machine learning to improve adherence to American Heart Association guidelines, according to the report.
Morari Medical is looking to aid in the confidence of male individuals with sexual dysfunction while SuraMedical looks to increase chronic leg wound treatment consistency through remote monitoring, according to the report.
Noleus Medical is developing a disposable device that aims to mitigate postoperative bowel swelling after abdominal surgery while Sunrise Health looks to provide patients with mental health or substance-abuse issues with anonymous, text-based group support, according to MinneInno.
In March, Boston Scientific joined the Mayo Clinic and the University of Minnesota in backing Gener8tor as it launched the gBeta medtech focused incubator in Minneapolis.
